Other side-effects have been reported: Pain at the injection point, itching, discolouration and sensitivity at the injection point.

Very rare (less than 0.01%): Injection site reaction

Rotate the injection sites and inject slowly to avoid discomfort at the site of injection.

Not known: fever, injection site reactions (including extensive swelling of the vaccinated limb, blisters at or around the injection site and injection site nodule which may persist for more than one month)

The fatty tissue under the skin at the injection area may shrink or thicken if you give the shot at the same spot too often.

Not known: injection site reactions (including extensive swelling of the vaccinated limb, blisters at or around the injection site and injection site nodule which may persist for more than one month)

The apparatus includes an oxidant (54) and fuel (25) supply at the primary injection point (32) followed by secondary injection of the remaining oxidant supply at specific intervals to achieve the desired thermal profile.

Not known: fever, injection site reactions (including extensive swelling of the vaccinated limb, blisters at or around the injection site and injection site nodule which may persist for more than one month)

Altered colour of the skin at the site of the injection

Local: local venous pain at the injection site with or without phlebitis or thrombophlebitis.

Rotate the injection sites (arms, thighs, upper buttocks, or stomach) to minimize injection site skin irritation.

Local: pain at the injection site with or without phlebitis or thrombophlebitis.

Local: pain at the injection site with or without phlebitis or thrombophlebitis.

Local: pain at the injection site with or without phlebitis or thrombophlebitis.

Local: local venous pain at the injection site with or without phlebitis or thrombophlebitis.